Shares of Medicure Inc. (CVE:MPH – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$0.89 and traded as low as C$0.72. Medicure shares last traded at C$0.89, with a volume of 6,996 shares changing hands.
Medicure Stock Performance
The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03. The stock has a market capitalization of C$9.29 million, a P/E ratio of -4.57 and a beta of 0.90. The business has a 50-day moving average price of C$0.80 and a 200 day moving average price of C$0.88.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- Options Trading – Understanding Strike Price
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 3 Fintech Stocks With Good 2021 Prospects
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Using the MarketBeat Dividend Yield Calculator
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
